FDA Further Limits Johnson & Johnson Covid Vaccine
Johnson & & Johnson was eclipsed long earlier by Pfizer and Moderna in the nation’s vaccination campaign; federal officials have said the mRNA vaccines produced by those companies are both more secure and more efficient. In a statement, Johnson & & Johnson said the F.D.A.’s action showed the already-known risk of the side effect, not new data on the rate at which it occurs. The number of deaths associated to the disorder activated by the Johnson & & Johnson’s vaccine does not appear to have increased much, if at all. About 17 million Americans have now gotten one dose of Johnson & & Johnson’s vaccine, and another 1.5 million have gotten a booster dose, according to the C.D.C.’s data.
Johnson & & Johnson was eclipsed long earlier by Pfizer and Moderna in the country’s vaccination campaign; federal officials have stated the mRNA vaccines produced by those business are both safer and more efficient. The number of deaths associated to the disorder activated by the Johnson & & Johnson’s vaccine does not appear to have actually risen much, if at all. About 17 million Americans have now gotten one dosage of Johnson & & Johnson’s vaccine, and another 1.5 million have gotten a booster dose, according to the C.D.C.’s data.